Drugs
Conditions
News and resources
MIMS Supported ResourcesValproate prescribing: changes to safety measures imminent
The Commission on Human Medicines (CHM) has recommended the introduction of new safety measures for valproate-containing medicines following a review of safety data relating to use of the anti-epileptic drug.
To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content. View our subscription and registration options.